| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
10 Accurate monitoring by QC-PCR of changes in circulating HIV-1 levels in ratients in response to antiviral therapy
|
|
|
1993
|
20 |
S1 |
p. 45-
1 p.
|
artikel
|
| 2 |
153 Accurate quantitation of varicella zoster virus (VZV) genomic DNA in infected rabbit ocular tissue using quantitative competitive PCR (QC-PCR)
|
|
|
1993
|
20 |
S1 |
p. 126-
1 p.
|
artikel
|
| 3 |
147 A comparison of ganciclovir and a phosphonate analogue, SR 3745A, for treatment of experimental cytomegalovirus infections
|
|
|
1993
|
20 |
S1 |
p. 123-
1 p.
|
artikel
|
| 4 |
75 Activity of BRL47923 and its oral prodrug, SB203657A against a rauscher murine leukaemia virus infection in mice
|
|
|
1993
|
20 |
S1 |
p. 80-
1 p.
|
artikel
|
| 5 |
131 Acyclovir sensitivity - fifteen years of clinical experience
|
|
|
1993
|
20 |
S1 |
p. 115-
1 p.
|
artikel
|
| 6 |
176 Acyclovir - 15 years of clinical experience
|
|
|
1993
|
20 |
S1 |
p. 137-
1 p.
|
artikel
|
| 7 |
244 Adenosine analogs as potential inhibitors of s-adenosylhomocysteine hydrolase
|
|
|
1993
|
20 |
S1 |
p. 173-
1 p.
|
artikel
|
| 8 |
48 Affinity purification of HIV and visna virus reverse transcriptases using a novel inhibitor
|
|
|
1993
|
20 |
S1 |
p. 66-
1 p.
|
artikel
|
| 9 |
179 5-Alkynyl pyrimidine nucleosides as potent selective inhibitors of varicella zoster virus (VZV)
|
|
|
1993
|
20 |
S1 |
p. 139-
1 p.
|
artikel
|
| 10 |
32 Amantadine analogues block early steps of HIV infection
|
|
|
1993
|
20 |
S1 |
p. 58-
1 p.
|
artikel
|
| 11 |
168 Analysis of consecutive HSV-2 strains isolated from a patient treated with (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) for relapsing perineal acyclovir-resistant HSV-2 lesions
|
|
|
1993
|
20 |
S1 |
p. 133-
1 p.
|
artikel
|
| 12 |
62 Analysis of reverse transcriptase (RT) nucleotide sequences from AZT resistant strains of HIV-1 suggest further possible sites of mutation may be involved in the development of drug resistance
|
|
|
1993
|
20 |
S1 |
p. 73-
1 p.
|
artikel
|
| 13 |
105 Analysis of the influenza virus endonuclease through the use of recombinant systems
|
|
|
1993
|
20 |
S1 |
p. 101-
1 p.
|
artikel
|
| 14 |
195 Analysis of the pharmacokinetics of the antiviral nucleoside analog FEAU in the woodchuck hepatitis virus model using FMAU as an internal standard for HPLC
|
|
|
1993
|
20 |
S1 |
p. 148-
1 p.
|
artikel
|
| 15 |
42 An assay for HIV RNA in crude infected cell lysates, and its use for the rapid evaluation of antiviral efficacy
|
|
|
1993
|
20 |
S1 |
p. 63-
1 p.
|
artikel
|
| 16 |
13 1, 5-Anhydrohexitol nucleoside analogues as new antiviral entities
|
|
|
1993
|
20 |
S1 |
p. 47-
1 p.
|
artikel
|
| 17 |
52 An in vitro model for determination of the rate of resistance development in HIV
|
Vrang, L.
|
|
1993
|
20 |
S1 |
p. 68-
1 p.
|
artikel
|
| 18 |
189 An open study to investigate the clinical potential, pharmacokinetics and safety of 882C in patients with herpes zoster
|
|
|
1993
|
20 |
S1 |
p. 144-
1 p.
|
artikel
|
| 19 |
223 A novel hybrid human interferon inhibits hepadnavirus reprication in , vitro and in vivo
|
|
|
1993
|
20 |
S1 |
p. 163-
1 p.
|
artikel
|
| 20 |
37 Antibody-targeted immunoliposomes containing antisense oligonucleotide mediate a specific antiviral effect on H9 cells infected with HIV-1
|
|
|
1993
|
20 |
S1 |
p. 61-
1 p.
|
artikel
|
| 21 |
115 Anti-herpes activity of biscationic distamycin analogues
|
|
|
1993
|
20 |
S1 |
p. 107-
1 p.
|
artikel
|
| 22 |
142 Antiherpesvirus activity of BRL 44385 (9-(3-hydroxypropoxy)guanine) in animals
|
|
|
1993
|
20 |
S1 |
p. 120-
1 p.
|
artikel
|
| 23 |
138 Antiherpetic activity, cytotoxicity and metabolism of non-nucleoside analogs related to toyocamycin, sangivamycin and thiosangivamycin
|
|
|
1993
|
20 |
S1 |
p. 118-
1 p.
|
artikel
|
| 24 |
41 Anti-HIV-1 activity of phosphorothioate oligonucleotides in chronically and acutely infected cells
|
|
|
1993
|
20 |
S1 |
p. 63-
1 p.
|
artikel
|
| 25 |
34 Anti-HIV efficacy of SDZ 811, a non-immunosuppressive cyclosporin derivative
|
Peichl, P.
|
|
1993
|
20 |
S1 |
p. 59-
1 p.
|
artikel
|
| 26 |
113 Antiviral activity and mechanism of action of GL-288-C8 on the replication of herpes simplex viruses (HSV) in human cells
|
|
|
1993
|
20 |
S1 |
p. 106-
1 p.
|
artikel
|
| 27 |
236 Antiviral activity of glutathione: In vitro inhibition of RNA and DNA virus replication
|
|
|
1993
|
20 |
S1 |
p. 169-
1 p.
|
artikel
|
| 28 |
133 Antiviral activity of nucleoside derivatives against thymidine kinase-deficient acyclovir resistant mutants of herpes simplex virus type 1
|
|
|
1993
|
20 |
S1 |
p. 116-
1 p.
|
artikel
|
| 29 |
248 Antiviral activity of (PALA) alone and in combination with rifampicin against vaccinia virus induced skin lesions in african green monkeys
|
|
|
1993
|
20 |
S1 |
p. 175-
1 p.
|
artikel
|
| 30 |
116 Antiviral activity of the benthic algae from the piran bay
|
Filipič, B.
|
|
1993
|
20 |
S1 |
p. 107-
1 p.
|
artikel
|
| 31 |
149 Antiviral activity of the new immunostimulator “vegetan” on the models of herpetic meningoencephalitis of mice and genital herpes of guinea pigs
|
|
|
1993
|
20 |
S1 |
p. 124-
1 p.
|
artikel
|
| 32 |
250 Antiviral activity of unithiolum as the result of disulphide bonds cracking
|
|
|
1993
|
20 |
S1 |
p. 176-
1 p.
|
artikel
|
| 33 |
190 Anti-viral approaches to inhibiting the replication of human papillomavirus DNA
|
|
|
1993
|
20 |
S1 |
p. 145-
1 p.
|
artikel
|
| 34 |
194 Antiviral effect of DNA gyrase inhibitors on the replication of duck hepatitis B virus in vivo
|
|
|
1993
|
20 |
S1 |
p. 147-
1 p.
|
artikel
|
| 35 |
237 Antiviral effect of flavonoids in combinations with interferon or nucleoside analogues
|
Béládi, I.
|
|
1993
|
20 |
S1 |
p. 170-
1 p.
|
artikel
|
| 36 |
117 Antiviral evaluation of A-73209, a potent, orally active agent against VZV and HSV infections
|
|
|
1993
|
20 |
S1 |
p. 108-
1 p.
|
artikel
|
| 37 |
240 Antiviral factor of noninterferon and noninterleukin origin
|
|
|
1993
|
20 |
S1 |
p. 171-
1 p.
|
artikel
|
| 38 |
264 Antiviral macromolecular therapeutic systems: Principles and methods of design
|
|
|
1993
|
20 |
S1 |
p. 183-
1 p.
|
artikel
|
| 39 |
Antiviral research branch enteric diseases branch national institute of allergy and infectious diseases national institutes of health
|
|
|
1993
|
20 |
S1 |
p. 188-189
2 p.
|
artikel
|
| 40 |
174 Antiviral therapy of acute retinal necrosis and cerebral vasculitis due to varicella zoster virus in HIV infected patients
|
|
|
1993
|
20 |
S1 |
p. 136-
1 p.
|
artikel
|
| 41 |
263 Arbidol - new antiviral drug
|
|
|
1993
|
20 |
S1 |
p. 183-
1 p.
|
artikel
|
| 42 |
123 A sensitive and accurate assay system for the screening of antiviral compounds against herpes simplex virus type 1 and type 2
|
|
|
1993
|
20 |
S1 |
p. 111-
1 p.
|
artikel
|
| 43 |
17 A single large dose of HPMPC is highly effective at inhibiting HCMV when administered in an in vitro drug delivery system
|
|
|
1993
|
20 |
S1 |
p. 49-
1 p.
|
artikel
|
| 44 |
Author index
|
|
|
1993
|
20 |
S1 |
p. 185-187
3 p.
|
artikel
|
| 45 |
80 AZT serum levels in long-term patients from whom sensitive or resistant viruses have been isolated
|
|
|
1993
|
20 |
S1 |
p. 82-
1 p.
|
artikel
|
| 46 |
249 Bcc as a vehicle for creation of recomebinant viral live vaccines
|
|
|
1993
|
20 |
S1 |
p. 176-
1 p.
|
artikel
|
| 47 |
154 Bovine herpes mammillitis virus inhibitors in vitro and in a novel guinea pig vaginal infection model
|
|
|
1993
|
20 |
S1 |
p. 126-
1 p.
|
artikel
|
| 48 |
235 Broad spectrum antiviral activity of mangrove plants
|
Premanathan, M.
|
|
1993
|
20 |
S1 |
p. 169-
1 p.
|
artikel
|
| 49 |
205 Broad spectrum antiviral antivities of sulfated mucopolysaccharides of a marine Pseudomonas strain
|
|
|
1993
|
20 |
S1 |
p. 154-
1 p.
|
artikel
|
| 50 |
112 Callx(n)arene sulfonates as novel antiviral agents
|
|
|
1993
|
20 |
S1 |
p. 105-
1 p.
|
artikel
|
| 51 |
72 Cation influence on survival and lymphoma in murine immuno-deficiency deficiency disease (MAIDS): Effects of lithium and magnesium in vivo
|
|
|
1993
|
20 |
S1 |
p. 78-
1 p.
|
artikel
|
| 52 |
208 Cell line-dependent activity of capsid-binding compounds against coxsackievirus B3
|
|
|
1993
|
20 |
S1 |
p. 155-
1 p.
|
artikel
|
| 53 |
96 Characterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
|
|
|
1993
|
20 |
S1 |
p. 95-
1 p.
|
artikel
|
| 54 |
139 Characterization of S-adenosylmethionine decarboxylase induced by Human cytomegalovirus
|
|
|
1993
|
20 |
S1 |
p. 119-
1 p.
|
artikel
|
| 55 |
161 Chemotherapy of EHV-1 induced abortion in a murine model
|
|
|
1993
|
20 |
S1 |
p. 130-
1 p.
|
artikel
|
| 56 |
230 Clinical features and response to interferon in patients with different HCV genotypes in Italy
|
Pontisso, P.
|
|
1993
|
20 |
S1 |
p. 166-
1 p.
|
artikel
|
| 57 |
121 CMV-associated DNA polymerase activity: Kineties, isolation, characterization and its potential application in the diagnosis of CMV disease
|
|
|
1993
|
20 |
S1 |
p. 110-
1 p.
|
artikel
|
| 58 |
175 CMV Retinitis resistant to foscarnet. A case with clinicovirological correlation
|
|
|
1993
|
20 |
S1 |
p. 137-
1 p.
|
artikel
|
| 59 |
140 Co-infection of herpes and pox viruses in BSC-1 cells in the presence of antiviral drugs
|
|
|
1993
|
20 |
S1 |
p. 119-
1 p.
|
artikel
|
| 60 |
122 Combination effects of a human monoclonal anti cytomegalovirus (CMV) antibody (MSL 109) and foscarnet or ganciclovir on CMV replication in vitro
|
|
|
1993
|
20 |
S1 |
p. 110-
1 p.
|
artikel
|
| 61 |
44 Combination of LY300082 with AZT and DDI give synergistic effects on HIV replication in cells and on HIV reverse transcriptase
|
|
|
1993
|
20 |
S1 |
p. 64-
1 p.
|
artikel
|
| 62 |
217 Combination therapy with amantadine and immunomodulators potentiates antiviral effects in influenza a virus-infected mice
|
|
|
1993
|
20 |
S1 |
p. 160-
1 p.
|
artikel
|
| 63 |
94 Combination therapy with AZT prevents selection of HIV-1 variants that are highly resistant to the nonnucleoside reverse transcriptase inhibitor L-697, 661
|
|
|
1993
|
20 |
S1 |
p. 94-
1 p.
|
artikel
|
| 64 |
102 Comparative anti-influenza virus activity of 2′-deoxy-2′ fluororibosides in vitro
|
|
|
1993
|
20 |
S1 |
p. 99-
1 p.
|
artikel
|
| 65 |
14 Comparative anti-viral effects of acyclovir and penciclovir (famciclovir)
|
|
|
1993
|
20 |
S1 |
p. 47-
1 p.
|
artikel
|
| 66 |
143 comparative efficacy of acyclovir (ACV) and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in the treatment of cutaneous HSV-1 and HSV-2 lesions in athymic-nude mice
|
|
|
1993
|
20 |
S1 |
p. 121-
1 p.
|
artikel
|
| 67 |
45 Comparative efficacy of HIV inhibitors on cells infected with cell free HIV or cocultivated with HIV-infected cells
|
|
|
1993
|
20 |
S1 |
p. 65-
1 p.
|
artikel
|
| 68 |
207 Comparative potencies of non-capsid-binding and capsid-binding antirhinovirus compounds
|
|
|
1993
|
20 |
S1 |
p. 155-
1 p.
|
artikel
|
| 69 |
61 Comparative rates of in vitro resistance development of HIV-1 to new non-nucleoside analog RT inhibitors
|
|
|
1993
|
20 |
S1 |
p. 73-
1 p.
|
artikel
|
| 70 |
11 Comparison of ddI and ZDV for the treatment of patients with AIDS or ARC, 6 months prior treatment with ZDV and increasing symptoms
|
|
|
1993
|
20 |
S1 |
p. 46-
1 p.
|
artikel
|
| 71 |
177 Comparison of two acyclovir tablet formulations for acute herpes zoster treatment
|
|
|
1993
|
20 |
S1 |
p. 138-
1 p.
|
artikel
|
| 72 |
Conference committees
|
|
|
1993
|
20 |
S1 |
p. 3-4
2 p.
|
artikel
|
| 73 |
69 Conformationally restricted analogs of a new class of potent non-nucleoside reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 77-
1 p.
|
artikel
|
| 74 |
70 Conformational studies on a new class of potent non-nucleoside reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 77-
1 p.
|
artikel
|
| 75 |
213 Control of virus replication by cyclopentenone prostaglandins: A multistage process, associated with induction of heat shock protein synthesis
|
|
|
1993
|
20 |
S1 |
p. 158-
1 p.
|
artikel
|
| 76 |
Corporate sponsors
|
|
|
1993
|
20 |
S1 |
p. 7-
1 p.
|
artikel
|
| 77 |
22 7-Deaza analogues of carbovir. Synthesis and antiviral evaluation
|
|
|
1993
|
20 |
S1 |
p. 52-
1 p.
|
artikel
|
| 78 |
26 1-Deazapurine derivatives: A new class of antiviral compounds
|
Vittori, S.
|
|
1993
|
20 |
S1 |
p. 54-
1 p.
|
artikel
|
| 79 |
63 Development of AZT and ddI resistance in individuals infected with HIV
|
|
|
1993
|
20 |
S1 |
p. 74-
1 p.
|
artikel
|
| 80 |
120 Dipyridamole potentiates the activity of acyclic nucleoside phosphonates against varicella-zoster virus (VZV), herpes simplex virus (HSV) and human cytomegalovirus (HCMV) in vitro
|
|
|
1993
|
20 |
S1 |
p. 109-
1 p.
|
artikel
|
| 81 |
85 Direct evidence using QC-PCR methods for persistent, high levels of circulating virus in acute and early-chronic HIV-1 infection
|
|
|
1993
|
20 |
S1 |
p. 85-
1 p.
|
artikel
|
| 82 |
261 Distribution to the brain, protein binding and log(P) 3′-fluorothymidine derivatives, a microdialysis study
|
Borg, N.
|
|
1993
|
20 |
S1 |
p. 182-
1 p.
|
artikel
|
| 83 |
197 Double blind, vehicle-controlled rising dose tolerance study of ISIS 2105, a phosphorothioate oligonucleotide for treatment of condyloma acuminatum
|
Hutcherson, S.L.
|
|
1993
|
20 |
S1 |
p. 149-
1 p.
|
artikel
|
| 84 |
Editorial Board
|
|
|
1993
|
20 |
S1 |
p. ii-
1 p.
|
artikel
|
| 85 |
148 Effective treatment of acyclovir resistant genital herpes simplex virus infections with 2′Fluoro-Arabinosyl pyrimidine nucleosides
|
|
|
1993
|
20 |
S1 |
p. 123-
1 p.
|
artikel
|
| 86 |
171 Effect of acyclovir + 348U87 cream on solar simulator induced herpes simplex labialis
|
|
|
1993
|
20 |
S1 |
p. 135-
1 p.
|
artikel
|
| 87 |
155 Effect of combined treatment with antibody and acyclovir on neonatal HSV infection in guinea pigs
|
|
|
1993
|
20 |
S1 |
p. 127-
1 p.
|
artikel
|
| 88 |
163 Effect of dexthan sulfate on experimental herpes simplex keratitis in rabbits
|
|
|
1993
|
20 |
S1 |
p. 131-
1 p.
|
artikel
|
| 89 |
50 Effect of drug resistance on combination chemotherapy for HIV
|
|
|
1993
|
20 |
S1 |
p. 67-
1 p.
|
artikel
|
| 90 |
78 Effect of human serum on the in vitro Anti-HIV-1 activity of hept derivatives as related to their lipophilicity and serum protein binding capacity
|
|
|
1993
|
20 |
S1 |
p. 81-
1 p.
|
artikel
|
| 91 |
242 Effect of staurosporine on the antiviral activity of human interferons
|
|
|
1993
|
20 |
S1 |
p. 172-
1 p.
|
artikel
|
| 92 |
64 Effect of suramin on in vitro HIV DNA integration reaction
|
Carteau, Sandrine
|
|
1993
|
20 |
S1 |
p. 74-
1 p.
|
artikel
|
| 93 |
67 Effects of anti-FMLV triple helix forming oligonucleotides on FMLV production in culture
|
|
|
1993
|
20 |
S1 |
p. 76-
1 p.
|
artikel
|
| 94 |
129 Effects of inhibitors of de novo pyrimidine biosynthesis on human cytomegalovirus DNA replication
|
|
|
1993
|
20 |
S1 |
p. 114-
1 p.
|
artikel
|
| 95 |
6 Effects of U-75875, a peptidomimetic inhibitor of retroviral protease, on simian immunodeficiency virus (SIV) infection in rhesus monkeys (Macaca mulatta)
|
|
|
1993
|
20 |
S1 |
p. 32-33
2 p.
|
artikel
|
| 96 |
19 Efficacy of foscarnet (PFA) induction treatment of human cytomegalovirus (HCMV) retinitis in AIDS patients: Quantitative virologic evaluation in blood and aqueous humor
|
|
|
1993
|
20 |
S1 |
p. 50-
1 p.
|
artikel
|
| 97 |
157 Efficacy of HSV-2 glycoprotein D vaccines against HSV-1 or HSV-2 genital challenge in guinea pigs
|
|
|
1993
|
20 |
S1 |
p. 128-
1 p.
|
artikel
|
| 98 |
150 Efficacy of (-)-9-[4-Hydroxy-2-(hydroxymethyl)butyl]guanine (H2G) in African green monkeys infected with simian varicella virus
|
|
|
1993
|
20 |
S1 |
p. 124-
1 p.
|
artikel
|
| 99 |
145 Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in the treatment of lethal vaccinia virus infection in mice with severe combined immune deficiency (SCID)
|
|
|
1993
|
20 |
S1 |
p. 122-
1 p.
|
artikel
|
| 100 |
158 Efficacy of topical capsaicin and it's less irritating cis-isomer, civamide, in the treatment of experimental genital herpes
|
|
|
1993
|
20 |
S1 |
p. 128-
1 p.
|
artikel
|
| 101 |
203 Establishment of a highly sensitive assay system for screening of anti-orthomyxo- and-paramyxoviruses agents
|
|
|
1993
|
20 |
S1 |
p. 153-
1 p.
|
artikel
|
| 102 |
16 Evaluation of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes
|
|
|
1993
|
20 |
S1 |
p. 48-
1 p.
|
artikel
|
| 103 |
185 Evaluation of nucleotide prodrugs as inhibitors of viral replication
|
|
|
1993
|
20 |
S1 |
p. 142-
1 p.
|
artikel
|
| 104 |
82 Evaluation of ribavirin in patients with generalized lymphadenopathy syndrome. 76 Weeks of follow-up
|
|
|
1993
|
20 |
S1 |
p. 83-
1 p.
|
artikel
|
| 105 |
136 Evaluation of the in vitro activity of SP-303 against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus (HSV)
|
|
|
1993
|
20 |
S1 |
p. 117-
1 p.
|
artikel
|
| 106 |
226 Evaluation of the potent anti-HBV agent (−)-5-fluoro-2′, 3′-dideoxy-3′-thiacytidine (FTC) in a novel in vivo model
|
|
|
1993
|
20 |
S1 |
p. 164-
1 p.
|
artikel
|
| 107 |
241 Experimental approaches to the fine immunochemical mapping of antigenic determinants on viral structural proteins
|
|
|
1993
|
20 |
S1 |
p. 172-
1 p.
|
artikel
|
| 108 |
232 Expression of cytokine and tumor suppressor genes in condyloma acuminata
|
|
|
1993
|
20 |
S1 |
p. 167-
1 p.
|
artikel
|
| 109 |
191 External guide sequences (EGS) elicit cleavage of hepatitis B virus RNA by RNase P
|
|
|
1993
|
20 |
S1 |
p. 146-
1 p.
|
artikel
|
| 110 |
54 (−)-5-Fluoro-2′,3′-dideoxy-3′-thiacytidine, FTC, is efficiently anabolised to nucleotides in human hepatocytes and CEM lymphoblastoid cells
|
|
|
1993
|
20 |
S1 |
p. 69-
1 p.
|
artikel
|
| 111 |
204 Fluorometric ELISA method for rapid antiviral susceptibility testing of respiratory synctial virus
|
|
|
1993
|
20 |
S1 |
p. 153-
1 p.
|
artikel
|
| 112 |
20 Foscarnet-resistant herpes simplex virus (HSV) infections in patients with AIDS
|
|
|
1993
|
20 |
S1 |
p. 51-
1 p.
|
artikel
|
| 113 |
56 FTC inhibition of HIV-1 RT and HBV DNA polymerase: Differential activity of stereolsomers
|
|
|
1993
|
20 |
S1 |
p. 70-
1 p.
|
artikel
|
| 114 |
5 Gene therapy of viral infections: The use of retroviral vectors expressing catalytic and antisense RNAs
|
Biasolo, M.A.
|
|
1993
|
20 |
S1 |
p. 31-
1 p.
|
artikel
|
| 115 |
109 Glyeosyl phosphotriesters of 5-FdU: Synthesis, transmembrane transport and antiviral activity
|
|
|
1993
|
20 |
S1 |
p. 104-
1 p.
|
artikel
|
| 116 |
31 gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: Prevention by memantine
|
|
|
1993
|
20 |
S1 |
p. 58-
1 p.
|
artikel
|
| 117 |
182 Growth of Epstein-Barr virus-immortalized cell lines is inhibited by specific antisense oligodeoxyribonucleotides
|
Pagano, J.S.
|
|
1993
|
20 |
S1 |
p. 141-
1 p.
|
artikel
|
| 118 |
101 4-Guanidino neu5Ac2en is a potent and broad spectrum inhibitor of influenza A and B viruses, in vitro and in vivo
|
|
|
1993
|
20 |
S1 |
p. 99-
1 p.
|
artikel
|
| 119 |
229 Hepatitis B virus recurrence following orthotopic liver transplantation pathogenesis and chemotherapy of severe infection
|
|
|
1993
|
20 |
S1 |
p. 166-
1 p.
|
artikel
|
| 120 |
84 High levels-of plasma virus detected during asymptomatic, as well as during acute and late stages of HIV-1 infection by quantitative competitive PCR (QC-PCR)
|
|
|
1993
|
20 |
S1 |
p. 84-
1 p.
|
artikel
|
| 121 |
3 Highly selective and potent inhibition of human immunodeficiency virus (HIV) by the novel bicyclam derivative JM31000
|
|
|
1993
|
20 |
S1 |
p. 22-
1 p.
|
artikel
|
| 122 |
53 HIV reverse transcriptases with point mutations as tools for drug development
|
Zhang, H.
|
|
1993
|
20 |
S1 |
p. 69-
1 p.
|
artikel
|
| 123 |
125 HSV1 Morphologic features after treatment with alkaline autooxidized catechinic acid (AOCA): Confirmation of in vitro activity
|
|
|
1993
|
20 |
S1 |
p. 112-
1 p.
|
artikel
|
| 124 |
93 Human immunodeficiency virus type 1 (HIV-1) mutant strains emerging after combination of HIV-1-specific inhibitors in cell culture
|
|
|
1993
|
20 |
S1 |
p. 94-
1 p.
|
artikel
|
| 125 |
49 5′-Hydrogenphosphonates of anti-HIV nucleoside analogues: Controversial mode of action
|
Imbach, J.-L.
|
|
1993
|
20 |
S1 |
p. 67-
1 p.
|
artikel
|
| 126 |
259 Hydrophobisation of virus specific antibodies and antisense oligonucleotite promotes their antiviral actions
|
|
|
1993
|
20 |
S1 |
p. 181-
1 p.
|
artikel
|
| 127 |
253 Immunomodulation effects of antiidiotypic antibodies by experimental venezuelan equine encephalomyelitis (VEE) infections
|
|
|
1993
|
20 |
S1 |
p. 178-
1 p.
|
artikel
|
| 128 |
254 Immunotherapy of the experimental Ebola fever
|
|
|
1993
|
20 |
S1 |
p. 178-
1 p.
|
artikel
|
| 129 |
83 Improvement of health status of HIV infected individuals treated with solutein™
|
|
|
1993
|
20 |
S1 |
p. 84-
1 p.
|
artikel
|
| 130 |
256 Influence of peroxidation of ribamydil-containing liposomes on the effects of chemotherapy on some experimental virus infections
|
|
|
1993
|
20 |
S1 |
p. 179-
1 p.
|
artikel
|
| 131 |
201 Influenza virus-inhibitory activity of a series of antisense oligonucleotides
|
|
|
1993
|
20 |
S1 |
p. 152-
1 p.
|
artikel
|
| 132 |
58 Inhibition of de novo pyrimidine pathway by 3′-azido-3′-deoxythymidine in human bone marrow cells: Rationale for uridine “rescue”
|
|
|
1993
|
20 |
S1 |
p. 71-
1 p.
|
artikel
|
| 133 |
118 Inhibition of herpes simplex virus infection by antisense oligonucleotides
|
|
|
1993
|
20 |
S1 |
p. 108-
1 p.
|
artikel
|
| 134 |
90 Inhibition of HIV replication by cyclosporin derivatives: Lack of correlation with immunosuppression
|
Rosenwirth, B.
|
|
1993
|
20 |
S1 |
p. 92-
1 p.
|
artikel
|
| 135 |
33 Inhibition of HIV-1 replication by cyclosporin derivatives: Mode of action studies
|
Harrison, R.
|
|
1993
|
20 |
S1 |
p. 59-
1 p.
|
artikel
|
| 136 |
51 Inhibition of HIV-1 RNase H by the non-nucleoside RT inhibitors 9-CL tibo and L-697, 661
|
Goobar-Larsson, L.
|
|
1993
|
20 |
S1 |
p. 68-
1 p.
|
artikel
|
| 137 |
199 Inhibition of influenza B and C viruses by aprotinin
|
|
|
1993
|
20 |
S1 |
p. 151-
1 p.
|
artikel
|
| 138 |
216 Inhibition of influenza virus infections in mice by the phenolic biopolymer SP303
|
|
|
1993
|
20 |
S1 |
p. 159-
1 p.
|
artikel
|
| 139 |
212 Inhibition of RNA virus replication by short hyperthermic treatment
|
|
|
1993
|
20 |
S1 |
p. 157-
1 p.
|
artikel
|
| 140 |
135 Inhibition of thymidylate synthetase activity induced in varicella-zoster virus infected cells by (E)-5-(2-bromovinyl)-2′-deoxyuridine
|
Yodota, Tomoyuki
|
|
1993
|
20 |
S1 |
p. 117-
1 p.
|
artikel
|
| 141 |
119 Inhibition of varicella-zoster virus by penciclovir in vitro studies
|
|
|
1993
|
20 |
S1 |
p. 109-
1 p.
|
artikel
|
| 142 |
60 Inhibition of wild type and mutant HIV reverse transcriptases by a new class of non-nucleoside reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 72-
1 p.
|
artikel
|
| 143 |
181 Inhibitors of Herpes simplex virus thymidine kinases
|
|
|
1993
|
20 |
S1 |
p. 140-
1 p.
|
artikel
|
| 144 |
183 Inhibitors of herpes simplex virus 1 uracil-DNA glycosylase
|
|
|
1993
|
20 |
S1 |
p. 141-
1 p.
|
artikel
|
| 145 |
144 Inhibitory effects of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine on murine adenovirus replication in vitro and in vivo
|
|
|
1993
|
20 |
S1 |
p. 121-
1 p.
|
artikel
|
| 146 |
29 Intracellular delivery of anti-HIV nucleotides
|
Puech, F.
|
|
1993
|
20 |
S1 |
p. 56-
1 p.
|
artikel
|
| 147 |
Introduction to sponsors
|
|
|
1993
|
20 |
S1 |
p. 5-6
2 p.
|
artikel
|
| 148 |
39 In vitro activity of alkaline autooxidized catechinic acid (AOCA) against HIV1
|
|
|
1993
|
20 |
S1 |
p. 62-
1 p.
|
artikel
|
| 149 |
200 In vitro activity of a novel series of polyoxosilicotungstates against human myxo-, herpes- and retroviruses
|
|
|
1993
|
20 |
S1 |
p. 151-
1 p.
|
artikel
|
| 150 |
134 In vitro acyclovir susceptibility monitoring of HSV clinical isolates
|
|
|
1993
|
20 |
S1 |
p. 116-
1 p.
|
artikel
|
| 151 |
202 In vitro and in ovo effects of various nucleoside and non-nucleoside analogues on influenza A and B virus replication
|
|
|
1993
|
20 |
S1 |
p. 152-
1 p.
|
artikel
|
| 152 |
221 In vitro anti-hepatitis B virus and anti-human cytomegalovirus activities of selected 2′, 2′-difluoro purine and pyrimidine nucleoside analogs
|
|
|
1993
|
20 |
S1 |
p. 162-
1 p.
|
artikel
|
| 153 |
128 In vitro antiviral activity of 1 - (beta - D - arabinofuranosyl) - 5 - ( - propynyl) uracil against varicella zoster virus
|
|
|
1993
|
20 |
S1 |
p. 113-
1 p.
|
artikel
|
| 154 |
38 In vitro antiviral activity studies of drug-polyanionic polymer combinations
|
|
|
1993
|
20 |
S1 |
p. 61-
1 p.
|
artikel
|
| 155 |
92 In vitro isolation of bicyclam-resistant variants of human immunodeficiency virus type 1
|
|
|
1993
|
20 |
S1 |
p. 93-
1 p.
|
artikel
|
| 156 |
184 In vitro metabolism and incorporation into nucleic acids of 2-bromo-5,6-dichloro-1-(β-D-ribofuranosyl)benzimidazole (BDCRB) in uninfected and HCMV-infected mammalian cells
|
|
|
1993
|
20 |
S1 |
p. 142-
1 p.
|
artikel
|
| 157 |
186 In vivo potentiation of acyclovir by methoxypolycthyleneglycol-thymidine phosphorylase
|
|
|
1993
|
20 |
S1 |
p. 143-
1 p.
|
artikel
|
| 158 |
28 Kinase bypass: A new strategy for antl-HIV drug design
|
McGuigan, C.
|
|
1993
|
20 |
S1 |
p. 55-
1 p.
|
artikel
|
| 159 |
46 Lack of inhibition of HIV replication in chronically infected macrophages by antiretroviral compounds
|
|
|
1993
|
20 |
S1 |
p. 65-
1 p.
|
artikel
|
| 160 |
73 Lack of involvement of transactivating herpesviruses in acute SIV infection in monkeys
|
Böttiger, D.
|
|
1993
|
20 |
S1 |
p. 79-
1 p.
|
artikel
|
| 161 |
86 L-carnitine in the treatment of HIV infection
|
|
|
1993
|
20 |
S1 |
p. 90-
1 p.
|
artikel
|
| 162 |
231 Leikinferon treatment of acute hepatitis B patients
|
|
|
1993
|
20 |
S1 |
p. 167-
1 p.
|
artikel
|
| 163 |
36 Liposome encapsulated anti-HIV agents: A new approach in AIDS therapy (in vitro studies)
|
|
|
1993
|
20 |
S1 |
p. 60-
1 p.
|
artikel
|
| 164 |
170 Long acting therapy of viral retinitis with HPMPC
|
Flores-Aguilar, M.
|
|
1993
|
20 |
S1 |
p. 134-
1 p.
|
artikel
|
| 165 |
245 Lypopolysacharide inhibits reproduction of amyotrophic leucospongiosis agent in vitro
|
|
|
1993
|
20 |
S1 |
p. 174-
1 p.
|
artikel
|
| 166 |
180 Mappicine ketone is a novel non-nucleoside inhibitor with in vitro antiviral activity against herpesviruses
|
|
|
1993
|
20 |
S1 |
p. 140-
1 p.
|
artikel
|
| 167 |
137 Maturation of concatameric viral DNA in HCMV-infected cells is prevented by the benzimidazole riboside, 2- bromo- 5,6- dichloro- 1- β- D- ribofuranosyl benzimidazole (BDCRB)
|
|
|
1993
|
20 |
S1 |
p. 118-
1 p.
|
artikel
|
| 168 |
211 Mechanism of PGA1-induced block of sendai virus protein synthesis
|
|
|
1993
|
20 |
S1 |
p. 157-
1 p.
|
artikel
|
| 169 |
7 Metabolism and In Vitro anti-retroviral activities of the bis(pivaloyloxymethyl) prodrug of acyclic 9-(2-phosphonyl methoxyethyl) adenine
|
|
|
1993
|
20 |
S1 |
p. 34-35
2 p.
|
artikel
|
| 170 |
156 Modification of primary and recurrent genital herpes in guinea pigs by passive immunoprophylaxis
|
|
|
1993
|
20 |
S1 |
p. 127-
1 p.
|
artikel
|
| 171 |
104 Molecular characterization of a poliovirus enhanced mutant selected by the antiviral compound 3(2H)-isoflavene
|
|
|
1993
|
20 |
S1 |
p. 100-
1 p.
|
artikel
|
| 172 |
160 New acycloguanosine analogue - furavir
|
|
|
1993
|
20 |
S1 |
p. 129-
1 p.
|
artikel
|
| 173 |
238 New antiviral preparation izatizon. Studies of the spectrum and of the antiviral directed mechanism
|
|
|
1993
|
20 |
S1 |
p. 170-
1 p.
|
artikel
|
| 174 |
89 New approaches for synthesizing antiviral nucleosides
|
|
|
1993
|
20 |
S1 |
p. 92-
1 p.
|
artikel
|
| 175 |
21 New highly potent HIV-1 protease inhibitors
|
Scholz, D.
|
|
1993
|
20 |
S1 |
p. 52-
1 p.
|
artikel
|
| 176 |
4 New strategies for gene therapy of A.I.D.S.
|
Parolin, Cristina
|
|
1993
|
20 |
S1 |
p. 23-30
8 p.
|
artikel
|
| 177 |
110 Novel non-nucleoside inhibitors of herpes viruses: Antiviral activity, structure-activity relationships, and pharmacokinetics of mappicine ketone and its derivatives
|
|
|
1993
|
20 |
S1 |
p. 104-
1 p.
|
artikel
|
| 178 |
247 N-phosphonoacetyl-l-aspartate (PALA): An effective and safe broad spectrum antiviral
|
|
|
1993
|
20 |
S1 |
p. 175-
1 p.
|
artikel
|
| 179 |
24 Nucleoside 5′-phosphonates: Synthesis, anti-HIV activities and reactions with DNA polymerases
|
|
|
1993
|
20 |
S1 |
p. 53-
1 p.
|
artikel
|
| 180 |
164 O-Alkyl and O-acyl prodrugs of sorivudine (BV-araU)
|
Machida, H.
|
|
1993
|
20 |
S1 |
p. 131-
1 p.
|
artikel
|
| 181 |
246 Organ distribution of a conjugate of adenine arabinoside monophosphate with lactosaminated albumin in rat
|
|
|
1993
|
20 |
S1 |
p. 174-
1 p.
|
artikel
|
| 182 |
239 Paradoxal effect of antiviral carbocyclic substances in subtoxic concentrations
|
|
|
1993
|
20 |
S1 |
p. 171-
1 p.
|
artikel
|
| 183 |
169 Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis
|
Flores-Aguilar, M.
|
|
1993
|
20 |
S1 |
p. 134-
1 p.
|
artikel
|
| 184 |
255 Peroral use of vaccinia virus. Results and prospects
|
|
|
1993
|
20 |
S1 |
p. 179-
1 p.
|
artikel
|
| 185 |
260 Pharmacokinetics and distribution to the brain of (R)-9-[4-hydroxy-2-(hydroxymethyl) butyl]guanine (H2G) and plasma levels of H2G after dosing a H2G prodrug in the rat
|
|
|
1993
|
20 |
S1 |
p. 181-
1 p.
|
artikel
|
| 186 |
193 Pharmacokinetics and metabolic disposition of (−)-5-pluoro-3′-thia-2′,3′-dideoxycytidine in mice, rats, and monkeys
|
|
|
1993
|
20 |
S1 |
p. 147-
1 p.
|
artikel
|
| 187 |
188 Phase i pharmacokinetics of the acyclovir prodrug, valacyclovir
|
|
|
1993
|
20 |
S1 |
p. 144-
1 p.
|
artikel
|
| 188 |
106 9-(2-Phosphonyl-methoxyethyl)adenine (PMEA) decreases the lethal effect of RNA-influenza virus in mice through an immunomodulating mechanism
|
|
|
1993
|
20 |
S1 |
p. 101-
1 p.
|
artikel
|
| 189 |
59 Phosphorylation of HIV-1 reverse transcriptase modulates its enzymatic activity
|
|
|
1993
|
20 |
S1 |
p. 72-
1 p.
|
artikel
|
| 190 |
219 Poliovirus thermostabilization by the pyridazinamine R 78206 without loss in infectivity
|
|
|
1993
|
20 |
S1 |
p. 161-
1 p.
|
artikel
|
| 191 |
79 Preclinical pharmacokinetic evaluation of selected members of a new class of potent HIV-1 reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 82-
1 p.
|
artikel
|
| 192 |
12 Prospective use of AZT resistance as a clinical decision-making tool in patients treated with AZT or ddI
|
|
|
1993
|
20 |
S1 |
p. 46-
1 p.
|
artikel
|
| 193 |
146 Protective activity of lipid A analogue GLA-60 against murine cytomegalovirus infection in mice
|
|
|
1993
|
20 |
S1 |
p. 122-
1 p.
|
artikel
|
| 194 |
258 Protective effect of aminoglicoside group antibiotics in experimental encephalitis of mice, induced by West-Nile virus
|
Azarova, I.A.
|
|
1993
|
20 |
S1 |
p. 180-
1 p.
|
artikel
|
| 195 |
132 Purification and characterization of an enzyme from rat liver that hydrolyzes 256U87, the L-valyl ester prodrug of acyclovir (ZOVIRAX®)
|
|
|
1993
|
20 |
S1 |
p. 115-
1 p.
|
artikel
|
| 196 |
65 Quantitative PCR analysis as an important tool for the evaluation of the activity of antiviral drugs in HIV-infected monocytes/macrophages
|
|
|
1993
|
20 |
S1 |
p. 75-
1 p.
|
artikel
|
| 197 |
77 Rabbit and mouse: Reliable animal models for HIV-I infection and for studies of anti-HIV-I activity of CD4 synthetic oligopeptides and AZT
|
Cereda, P.M.
|
|
1993
|
20 |
S1 |
p. 81-
1 p.
|
artikel
|
| 198 |
130 Rapid detection of thymidine kinase (TK)-positive and negative varicella-zoster virus (VZV) isolates using 1-β-D-arabinofuranosyl-E-5-(2-[125I]-iodovinyl)uracil (125IVaraU) plaque autoradiography (PA)
|
|
|
1993
|
20 |
S1 |
p. 114-
1 p.
|
artikel
|
| 199 |
233 RB tumor suppressor gene: A potential target of interferons in HPV infected cells
|
|
|
1993
|
20 |
S1 |
p. 168-
1 p.
|
artikel
|
| 200 |
95 Real-time characterization of the interaction of HIV-1-specific inhibitors with their binding site at the HIV-1 reverse transcriptase (RT) using surface plasmon resonance and biosensor technology
|
|
|
1993
|
20 |
S1 |
p. 95-
1 p.
|
artikel
|
| 201 |
91 Replication and infectivity of HIV in chronically-infected macrophages and lymphocytes is selectively blocked by protease inhibitors
|
|
|
1993
|
20 |
S1 |
p. 93-
1 p.
|
artikel
|
| 202 |
210 Resistence of parainfluenza virus I induced by treatment witn yeast enzyme complex
|
|
|
1993
|
20 |
S1 |
p. 156-
1 p.
|
artikel
|
| 203 |
257 Revealing of adenosine triphosphorig acid antiviral properties
|
Zubovich, I.K.
|
|
1993
|
20 |
S1 |
p. 180-
1 p.
|
artikel
|
| 204 |
222 Revealing of virus hepatis a inhibitors among spasmolitic drugs
|
|
|
1993
|
20 |
S1 |
p. 162-
1 p.
|
artikel
|
| 205 |
265 Reversal of the antiviral action of ribavirin
|
|
|
1993
|
20 |
S1 |
p. 184-
1 p.
|
artikel
|
| 206 |
166 Ribavirin in genital herpes. Results of a three-phase study
|
|
|
1993
|
20 |
S1 |
p. 132-
1 p.
|
artikel
|
| 207 |
81 Ribavirin versus zidovudine in children with advanced human immunodeficiency virus disease: Mexican expecience in 18 months of follou-up
|
|
|
1993
|
20 |
S1 |
p. 83-
1 p.
|
artikel
|
| 208 |
227 Ribozyme mediated cleavage of hepatitis B virus surface antigen mRNA
|
George, Shaji T.
|
|
1993
|
20 |
S1 |
p. 165-
1 p.
|
artikel
|
| 209 |
74 (R)-9-(2-Phosphonylmethoxypropyl)-2, 6-diaminopurine [(R)-PMPDAP]: A potent anti-retrovirus agent in vitro and in vivo
|
|
|
1993
|
20 |
S1 |
p. 79-
1 p.
|
artikel
|
| 210 |
218 Safety and efficacy of intranasal pirodavir (R77975) for treatment of naturally occurring common colds
|
|
|
1993
|
20 |
S1 |
p. 160-
1 p.
|
artikel
|
| 211 |
71 SAR studies optimizing HIV-1 inhibiting activities of LY73497, a new series of non-nucleoside inhibitors of reverse transcriptase
|
|
|
1993
|
20 |
S1 |
p. 78-
1 p.
|
artikel
|
| 212 |
Scientific program
|
|
|
1993
|
20 |
S1 |
p. 10-11
2 p.
|
artikel
|
| 213 |
55 Selection of human immunodeficiency virus type 1 (Hiv-1) resistant to the nucleoside inhibitor 2′,3′-dideoxy-5-fluoro-3′-thiacytidine (Ftc) in cell culture due to a single mutation in the reverse transcriptase
|
|
|
1993
|
20 |
S1 |
p. 70-
1 p.
|
artikel
|
| 214 |
215 Selective inhibitory effect of Ribavirine (virazole) on the reproduction strains of HSV-1 with drug resistance
|
|
|
1993
|
20 |
S1 |
p. 159-
1 p.
|
artikel
|
| 215 |
57 Semisynthetic antitumor alkaloids derivatives as a antiviral and a potential anti-HIV preparations
|
|
|
1993
|
20 |
S1 |
p. 71-
1 p.
|
artikel
|
| 216 |
15 Sequence-specific antiviral activity of a phosphorothioate oligonucleotide complementary to immediate early mRNA of human cytomegalovirus
|
|
|
1993
|
20 |
S1 |
p. 48-
1 p.
|
artikel
|
| 217 |
167 (S)-1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC): Successful topical treatment of acyclovir-resistant HSV-2 perineal lesions in an AIDS patient
|
|
|
1993
|
20 |
S1 |
p. 133-
1 p.
|
artikel
|
| 218 |
152 Single and combination intravenous therapy using USNUS-08 and DHPG during HCMV chorioretinal disease in the rabbit
|
|
|
1993
|
20 |
S1 |
p. 125-
1 p.
|
artikel
|
| 219 |
Social functions
|
|
|
1993
|
20 |
S1 |
p. 8-9
2 p.
|
artikel
|
| 220 |
108 Some aromatic acyclonucleoside analogs
|
|
|
1993
|
20 |
S1 |
p. 103-
1 p.
|
artikel
|
| 221 |
103 Specific inhibition of influenza transcriptase by 2′-Deoxy-2′-fluoroguanosine
|
|
|
1993
|
20 |
S1 |
p. 100-
1 p.
|
artikel
|
| 222 |
66 Specific inhibition of retroviruses and retrovirus activated oncoproteins by antisense oligonucleotides
|
|
|
1993
|
20 |
S1 |
p. 75-
1 p.
|
artikel
|
| 223 |
98 Structural analysis of the non-nucleoside binding site of HIV-1 reverse transcriptase
|
Klunder, J.
|
|
1993
|
20 |
S1 |
p. 97-
1 p.
|
artikel
|
| 224 |
68 Structural and conformational studies on a new class of non-nucleoside reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 76-
1 p.
|
artikel
|
| 225 |
225 Studies on the virus encoded protease, NS3, of hepatitis C virus
|
|
|
1993
|
20 |
S1 |
p. 164-
1 p.
|
artikel
|
| 226 |
252 Study in the monkeys P. hamadryas the possibility of the specific profylaxis of the Ebola fever
|
|
|
1993
|
20 |
S1 |
p. 177-
1 p.
|
artikel
|
| 227 |
99 Successful combination therapy in a novel animal model of concomitant retroviral/lethal opportunistic fungal infection
|
|
|
1993
|
20 |
S1 |
p. 98-
1 p.
|
artikel
|
| 228 |
124 Susceptibility of HCMV clinical isolates to ganciclovir (GCV) and hpmpc
|
|
|
1993
|
20 |
S1 |
p. 111-
1 p.
|
artikel
|
| 229 |
40 Synthesis and anti-HIV activity of new DABO derivatives
|
|
|
1993
|
20 |
S1 |
p. 62-
1 p.
|
artikel
|
| 230 |
206 Synthesis and anti-HRV activity of new disoxaril analogues
|
|
|
1993
|
20 |
S1 |
p. 154-
1 p.
|
artikel
|
| 231 |
30 Synthesis and antiretroviral activity of fluorinated benzodiazepones: Analogues of nevirapine
|
|
|
1993
|
20 |
S1 |
p. 57-
1 p.
|
artikel
|
| 232 |
23 Synthesis and anti-viral activity of 3′-azido-2′,3′-dideoxy-2′, 2-difluoro-β-d-ribofuranosyl nucleosides
|
|
|
1993
|
20 |
S1 |
p. 53-
1 p.
|
artikel
|
| 233 |
198 Synthesis and antiviral evaluation of imidazo[1,5-a]-1,3,5-triazine (5,8-diaza-7,9-dideazapurine) derivatives
|
Golankiewicz, B.
|
|
1993
|
20 |
S1 |
p. 150-
1 p.
|
artikel
|
| 234 |
192 Synthesis and biological evaluation of D-(2S) and L-(2R)-1,3-oxathiolanyl- and D-(2R)-and L-(2S)-1,3-dioxolanyl-nucleoside as anti-HIV and anti-HBV agents
|
Chu, C.K.
|
|
1993
|
20 |
S1 |
p. 146-
1 p.
|
artikel
|
| 235 |
27 Synthesis and in vitro antiviral activity of 8-aza-analogues of the potent antiviral agents 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) and 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG)
|
|
|
1993
|
20 |
S1 |
p. 55-
1 p.
|
artikel
|
| 236 |
114 Synthesis, antiviral activity, and pharmacokinetics of an N7-isomeric 2-aminopurine nucleoside analogue (I)
|
|
|
1993
|
20 |
S1 |
p. 106-
1 p.
|
artikel
|
| 237 |
88 Synthesis, enzymology and anti-HIV activity of chiral isomeric nucleosides
|
|
|
1993
|
20 |
S1 |
p. 91-
1 p.
|
artikel
|
| 238 |
1 Synthesis, mode of interaction with the enzyme and biological activities of a series of novel inhibitors of HIV-proteinase derived from penicillins
|
Humber, DC
|
|
1993
|
20 |
S1 |
p. 11-19
9 p.
|
artikel
|
| 239 |
111 Synthesis of acyclonucleoside phosphonates as antivirae agents
|
|
|
1993
|
20 |
S1 |
p. 105-
1 p.
|
artikel
|
| 240 |
2 Synthesis of carbocyclic nucleosides, nucleotides and analogues possessing anti-HIV activity
|
Roberts, S.M.
|
|
1993
|
20 |
S1 |
p. 20-21
2 p.
|
artikel
|
| 241 |
87 Synthesis of new carbocyclic analogues of 3′-deoxy-purine-ribonucleosides with potential antiviral activity
|
|
|
1993
|
20 |
S1 |
p. 90-
1 p.
|
artikel
|
| 242 |
25 Synthesis of sangivamycin derivatives as potential inhibitors of protein kinases
|
|
|
1993
|
20 |
S1 |
p. 54-
1 p.
|
artikel
|
| 243 |
97 Synthetic RNA targets for HIV-1 tat and rev proteins
|
|
|
1993
|
20 |
S1 |
p. 96-
1 p.
|
artikel
|
| 244 |
209 Testing the action of yeast enzyme complex on the replication of rna on virus influenza A/PR8
|
|
|
1993
|
20 |
S1 |
p. 156-
1 p.
|
artikel
|
| 245 |
43 The discovery and general SAR studies of a novel class of potent non-nucleoside reverse transcriptase inhibitors
|
|
|
1993
|
20 |
S1 |
p. 64-
1 p.
|
artikel
|
| 246 |
35 The effect of immunocorrectors on HIV-1 production in vitro
|
Barinsky, I.F.
|
|
1993
|
20 |
S1 |
p. 60-
1 p.
|
artikel
|
| 247 |
162 The effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) against EHV-1 in mice: Primary and secondary infections
|
|
|
1993
|
20 |
S1 |
p. 130-
1 p.
|
artikel
|
| 248 |
220 The in vitro anti-hepatitis B virus activity of FIAU is selective, reversible, and determined, at least in part, by the host cell
|
|
|
1993
|
20 |
S1 |
p. 161-
1 p.
|
artikel
|
| 249 |
172 The natural history of experimental ultraviolet radiation(UVR)-induced herpes labialis, a human model of recurrent herpes simplex virus infection: Clinical, virologic and serologic observations following multiple exposures
|
|
|
1993
|
20 |
S1 |
p. 135-
1 p.
|
artikel
|
| 250 |
141 The nine carboxyterminal aminoacids of HSV ribonucleotide reductase fused to an heterologous protein are capable of binding the large subunit of the enzyme
|
Marcello, A.
|
|
1993
|
20 |
S1 |
p. 120-
1 p.
|
artikel
|
| 251 |
76 The nude mouse transplanted with HIV infected cells as a model for the evaluation of antivirals
|
|
|
1993
|
20 |
S1 |
p. 80-
1 p.
|
artikel
|
| 252 |
228 The observation on the antiviral effect of ribavirin and combining with interferon in patients with chronic hepatitis B
|
|
|
1993
|
20 |
S1 |
p. 165-
1 p.
|
artikel
|
| 253 |
165 The pharmacokinetics of 882C, a thymidine analogue with potent anti-VZV activity, in healthy volunteers
|
|
|
1993
|
20 |
S1 |
p. 132-
1 p.
|
artikel
|
| 254 |
214 The remantadin inhibition activity at the earliest stages of virus-membrane interaction
|
|
|
1993
|
20 |
S1 |
p. 158-
1 p.
|
artikel
|
| 255 |
18 The safety, pharmacokinetics, and Anti-CMV activity of weekly HPMPC in HIV positive patients excreting CMV
|
|
|
1993
|
20 |
S1 |
p. 49-
1 p.
|
artikel
|
| 256 |
The seventh international conference on antiviral research 27 February – March 1994 Omni Hotel Charleston, South Carolina, USA
|
|
|
1993
|
20 |
S1 |
p. 190-
1 p.
|
artikel
|
| 257 |
243 The study of a new antiviral drug arbidol using ELISA KITS
|
|
|
1993
|
20 |
S1 |
p. 173-
1 p.
|
artikel
|
| 258 |
100 The synthesis and antipicornaviral activity of tetrazole analogues of win 54954
|
|
|
1993
|
20 |
S1 |
p. 98-
1 p.
|
artikel
|
| 259 |
187 Topical HPMPC is the first effective broad-spectrum antiviral to inhibit both HSV-1 and adenovirus in the NZ rabbit eye models
|
|
|
1993
|
20 |
S1 |
p. 143-
1 p.
|
artikel
|
| 260 |
126 Toxicity of antivirals on cultured human corneal cells
|
|
|
1993
|
20 |
S1 |
p. 112-
1 p.
|
artikel
|
| 261 |
262 Toxicological research on mopyridone a new drug with antiviral activity
|
|
|
1993
|
20 |
S1 |
p. 182-
1 p.
|
artikel
|
| 262 |
178 Treatment by gancyclovir of HCMV infection in lung trasplant patients monitored by PCR and viral isolation
|
|
|
1993
|
20 |
S1 |
p. 138-
1 p.
|
artikel
|
| 263 |
196 Treatment of chronic hepatitis C with different regimes of interferon alpha-2a
|
|
|
1993
|
20 |
S1 |
p. 148-
1 p.
|
artikel
|
| 264 |
224 Treatment of chronic woodchuck hepatitis virus infection with thymosin alpha-1 (TA1)
|
|
|
1993
|
20 |
S1 |
p. 163-
1 p.
|
artikel
|
| 265 |
234 Trental as a wide-spectrum inhibitor of virus activity
|
Votyakov, V.I.
|
|
1993
|
20 |
S1 |
p. 168-
1 p.
|
artikel
|
| 266 |
8 Two new (newborn) mouse models - harvey murine sarcoma virus (MSV-Har) and rauscher murine leukaemia virus (RLV), for anti retroviral drug testing
|
|
|
1993
|
20 |
S1 |
p. 35-42
8 p.
|
artikel
|
| 267 |
127 Use of differential polymerase chain reaction in quantitating viremia in varicella zoster virus infections
|
|
|
1993
|
20 |
S1 |
p. 113-
1 p.
|
artikel
|
| 268 |
107 Use of microdialysis to study drug distribution of antiviral compounds
|
|
|
1993
|
20 |
S1 |
p. 102-
1 p.
|
artikel
|
| 269 |
159 Use of passive antibody (Ab) to modify congenital guinea pig CMV infection
|
|
|
1993
|
20 |
S1 |
p. 129-
1 p.
|
artikel
|
| 270 |
173 Use of viral blood cultures in diagnosing herpes simplex virus infection in immunocompromised patients
|
|
|
1993
|
20 |
S1 |
p. 136-
1 p.
|
artikel
|
| 271 |
151 Varicella encephalitis after prolonged steroid treatment of varicella uveitis in a nonhuman primate
|
|
|
1993
|
20 |
S1 |
p. 125-
1 p.
|
artikel
|
| 272 |
47 Virucidal activity of available chlorine against the human immunodeficiency virus type 1 and the effects of protein concentration on this activity
|
|
|
1993
|
20 |
S1 |
p. 66-
1 p.
|
artikel
|
| 273 |
251 Virus-indueed dyslipidemias and problem of their antiviral chemotherapy
|
|
|
1993
|
20 |
S1 |
p. 177-
1 p.
|
artikel
|
| 274 |
9 Zidovudine (AZT)-induced down regulation of erythropoietin-receptors (Epo-R) and inhibition of protein kinase C (PKC) in the primate bone marrow cells (BMC)
|
|
|
1993
|
20 |
S1 |
p. 43-
1 p.
|
artikel
|
Tijdschrift beschrijving